The 130-kDa smooth muscle myosin light chain kinase is ubiquitously expressed in adult tissues, including cardiac muscle, whereas skeletal muscle MLCK is tissue-specific.
Answers are grounded in this paper and cite their sources.
smMLCK ubiquity in cardiac muscle cautions against off-target effects; extends adult isoform mapping but leaves human translation open.
The purpose of this study was to characterize myosin light chain kinase (MLCK) expression in cardiac and skeletal muscle. The only classic MLCK detected in cardiac tissue, purified cardiac myocytes, and in a cardiac myocyte cell line (AT1) was identical to the 130-kDa smooth muscle MLCK (smMLCK). A complex pattern of MLCK expression was observed during differentiation of skeletal muscle in which the 220-kDa-long or "nonmuscle" form of MLCK is expressed in undifferentiated myoblasts. Subsequently, during myoblast differentiation, expression of the 220-kDa MLCK declines and expression of this form is replaced by the 130-kDa smMLCK and a skeletal muscle-specific isoform, skMLCK in adult skeletal muscle. These results demonstrate that the skMLCK is the only tissue-specific MLCK, being expressed in adult skeletal muscle but not in cardiac, smooth, or nonmuscle tissues. In contrast, the 130-kDa smMLCK is ubiquitous in all adult tissues, including skeletal and cardiac muscle, demonstrating that, although the 130-kDa smMLCK is expressed at highest levels in smooth muscle tissues, it is not a smooth muscle-specific protein.
No takes yet. Share an insight, caveat, or question.
Herring et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: